ARYD — ARYA Sciences Acquisition IV Cashflow Statement
0.000.00%
Last trade - 00:00
- $85.39m
- $87.54m
- 28
- 34
- 40
- 26
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -0.014 | -6.56 | 1.07 | -2.13 |
Non-Cash Items | 0.011 | -0.052 | -2.08 | -2.62 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 0.002 | 5.54 | 0.524 | 4.03 |
Change in Prepaid Expenses | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Cash from Operating Activities | 0 | -1.07 | -0.485 | -0.726 |
Other Investing Cash Flow Items | — | -150 | 0 | 114 |
Sale/Maturity of Investment | ||||
Purchase of Investments | ||||
Cash from Investing Activities | — | -150 | 0 | 114 |
Financing Cash Flow Items | — | -3.42 | -0.045 | 0 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | — | 151 | 0.075 | -113 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0 | 0.501 | -0.41 | -0.071 |